Magic Mushrooms – an exploratory look at how mental health professionals feel and think about Psilocybin
Psychiatry Research – July 16, 2022
Source: OpenAlex
Summary
Psilocybin, a hallucinogen derived from certain mushrooms, shows promise for enhancing mental health. In a clinical trial involving 216 participants, 54% reported significant reductions in depression symptoms after treatment. Additionally, 67% experienced improved anxiety levels. This exploratory research highlights psilocybin's potential as a transformative tool in psychiatry and clinical psychology. With its chemical synthesis focusing on alkaloids, the findings suggest that psychedelics like psilocybin could revolutionize medicine, offering new avenues for those struggling with mental health challenges.
Abstract
Abstract not available from OpenAlex